Russian clinical trial approvals up 9% in 2008
The Russian agency cleared a total of 615 new trials in 2008, 282 of which were Phase III studies, 152 Phase II, 62 Phase IV and 38 Phase I, according to the latest report from Moscow-based contract research organisation (CRO) Synergy Research Group. The number of Phase III trials rose by 22% over 2007, while there were 4% fewer Phase II studies and 3% more Phase IV studies. The Phase I tally rose by 19% year-on-year.
Read More




